Home › Therapeutic areas › Oncology › Melanoma

Melanoma (16 companies)

Companies with an active program in Melanoma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
BCTX BriaCell Therapeutics Oncology 1 Phase 3 $30.7M 8
CMPX Compass Therapeutics Oncology 1 Phase 2 $109M 15
CTMX CytomX Therapeutics Oncology 1 Phase 1 $423M 7
EIKN Eikon Therapeutics Oncology 1 Phase 2 $279M 13
EXEL Exelixis CardiovascularOncology 1 Approved $16.7B 23
IDYA IDEAYA Biosciences Oncology 2 NDA Submitted $2.65B 15
IMTX Immatics Oncology 3 Phase 3 $958M 8
IMRX Immuneering Oncology 1 Phase 3 $224M 5
IMCR Immunocore DermatologyInfectious Disease+2 4 Approved $1.44B 12
MDNAF Medicenna Therapeutics Oncology 1 Phase 2 $14.8M 10
NRIX Nurix Therapeutics ImmunologyNeurology+1 1 Phase 3 $1.56B 13
CATX Perspective Therapeutics Oncology 1 Phase 1 $104M 5
PHIO Phio Pharmaceuticals Oncology 1 Phase 1 $8.6M 4
RLAY Relay Therapeutics DermatologyOncology Rare 1 Approved $3.64B 4
REPL Replimune Group Oncology 2 Approved $1.87B 5
HURA TuHURA Biosciences Oncology 1 Phase 3 $92.1M 4